As of 2026-08-24, iRadimed Corporation (IRMD) has a 3-month relative strength percentile of 37 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 49. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.2%, relative volume 0.62×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
IRMD appears in 1 ETF as of Jun 2026: PSC at 0.04% weight, $940K notional.
Held by 67 ETFs · $106M across latest filings · largest weight 2.77% (SAWS).
Top 1 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| PSC | 0.04% | $940K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IRMD Jan avg: 6.93% median: 4.14% win: 75% σ: 18.86% n: 4 2022-04-12 → 2026-07-31 | IRMD Feb avg: -0.08% median: 1.43% win: 75% σ: 6.26% n: 4 2022-04-12 → 2026-07-31 | IRMD Mar avg: -0.30% median: 0.51% win: 50% σ: 5.56% n: 4 2022-04-12 → 2026-07-31 | IRMD Apr avg: -7.22% median: -7.68% win: 20% σ: 10.48% n: 5 2022-04-12 → 2026-07-31 | IRMD May avg: 7.20% median: 8.65% win: 80% σ: 5.35% n: 5 2022-04-12 → 2026-07-31 | IRMD Jun avg: 3.50% median: 3.46% win: 100% σ: 1.39% n: 5 2022-04-12 → 2026-07-31 | IRMD Jul avg: 3.09% median: -2.43% win: 40% σ: 13.09% n: 5 2022-04-12 → 2026-07-31 | IRMD Aug avg: 2.34% median: 2.89% win: 75% σ: 18.39% n: 4 2022-04-12 → 2026-07-31 (current) | IRMD Sep avg: -2.27% median: -2.90% win: 25% σ: 7.24% n: 4 2022-04-12 → 2026-07-31 | IRMD Oct avg: -1.41% median: -2.69% win: 25% σ: 6.77% n: 4 2022-04-12 → 2026-07-31 | IRMD Nov avg: 10.11% median: 8.66% win: 100% σ: 8.21% n: 4 2022-04-12 → 2026-07-31 | IRMD Dec avg: 2.52% median: 3.17% win: 75% σ: 5.18% n: 4 2022-04-12 → 2026-07-31 |